The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2004
DOI: 10.1258/000456304322879971
|View full text |Cite
|
Sign up to set email alerts
|

Cholinesterase: phenotyping and genotyping

Abstract: The plasma enzyme butyrylcholinesterase (BChE) is of clinical interest because of the occurrence of genetic variants with decreased ability to hydrolyse, and therefore inactivate, muscle-relaxant drugs such as suxamethonium. Analysis of BChE involves the determination of both enzyme activity and biochemical phenotypes which are used to determine the risk of so-called 'scoline apnoea'. Problems in analysis arise from both the lack of a universally accepted reference method and the variety of substrates and cond… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
32
0
1

Year Published

2005
2005
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 27 publications
(34 citation statements)
references
References 59 publications
1
32
0
1
Order By: Relevance
“…In a multivariate model, plasma cholinesterase activity was correlated with severe cocaine toxicity in ED patients [50]. There are several phenotypes of human butylcholinesterase, and these may vary in their affinity for cocaine [51]. Interestingly, administration of repeated doses of cocaine may increase plasma butylcholinesterase activity [52].…”
Section: Cocaine-protein Bindingmentioning
confidence: 99%
“…In a multivariate model, plasma cholinesterase activity was correlated with severe cocaine toxicity in ED patients [50]. There are several phenotypes of human butylcholinesterase, and these may vary in their affinity for cocaine [51]. Interestingly, administration of repeated doses of cocaine may increase plasma butylcholinesterase activity [52].…”
Section: Cocaine-protein Bindingmentioning
confidence: 99%
“…79 BChE is synthesized primarily in the liver and is distributed throughout the intestinal mucosa, plasma and the brain. 80 For these reasons, BChE has been conceptualized as a therapeutic agent for CoD. 53 Researchers hypothesize that polymorphisms in BCHE lead to various enzyme profiles that allow different concentrations of cocaine to reach the reward system in the brain, thereby influencing susceptibility to developing addiction.…”
Section: Discussionmentioning
confidence: 99%
“…Differences in AChE enzyme activity can be explained by genetic causes that could underlie differences in AChE activity according to distinct alleles [35] or single-nucleotide polymorphisms [36]. This has been documented for butylcholinesterase [37], another non-specific cholinesterase found in humans. This may then suggest that genetics underlying AChE activity could play a role in determining whether patients develop the hypoactive or hyperactive subtype of delirium.…”
Section: Discussionmentioning
confidence: 99%